VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies Week 2022 | Upscaling cell and gene therapy manufacturing

Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., talks on the growing interest in developing technologies to improve cell and gene therapy manufacturing, notably in implementing automated processes. Mr Lehmicke emphasizes the importance of standardizing these processes. This interview took place at Advanced Therapies Week 2022.

Disclosures

Michael Lehmicke is the Senior Director of Science & Industry Affairs at Alliance for Regenerative Medicine.